StockData

ON Semiconductor vs Texas Instruments

ON and TXN side by side, both in electronic components and accessories. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ON and TXN compare

Texas Instruments is the larger company, worth 9.8 times as much as ON Semiconductor ($275B against $27.9B).

On earnings, Texas Instruments is cheaper: it trades at 45.8× trailing earnings, against 45.9× for ON Semiconductor.

Texas Instruments grew revenue faster over the last twelve months (16.7% versus −3.1% for ON Semiconductor).

Texas Instruments keeps more of each dollar of sales as profit, with a net margin of 31.1% compared with 10.2% at ON Semiconductor.

Texas Instruments pays a dividend yielding 2.4%; ON Semiconductor does not pay one.

Texas Instruments scores higher on the StockData Score (13 against 8 for ON Semiconductor), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricONTXN
Size and price
Market cap$27.9B$275B
Share price$71.67$300.84
Change, 1 year39.4%87.7%
Change, 5 years21.2%55.6%
Beta (5Y)1.581.12
Employees26K33K
StockData Score
Total score813 (better)
Valuation score00
Growth score13 (better)
Performance score24 (better)
Health score5 (better)3
Dividend score03 (better)
Valuation
P/E45.9×45.8× (better)
P/S4.5× (better)14.1×
P/B3.9× (better)15.3×
EV/EBITDA19.5× (better)38.8×
P/FCF18.6× (better)51.3×
FCF yield5.4% (better)1.9%
Fair value$51.54$190.34
Margin of safety−39.1% (better)−58.1%
Growth
Revenue growth (TTM)−3.1%16.7% (better)
Revenue growth, 5Y average2.7%4.1% (better)
Net income growth (TTM)35.3% (better)20.1%
EPS growth (TTM)45.8% (better)20.3%
EPS growth, 5Y average−12.3%−1.8% (better)
Profitability
Gross margin37.7%58.3% (better)
Operating margin10.8%37.3% (better)
Net margin10.2%31.1% (better)
FCF margin24.2%27.5% (better)
Return on equity8.3%35.2% (better)
Return on invested capital6.5%25.3% (better)
Financial health
Debt / equity0.62 (better)0.78
Net debt / EBITDA0.41 (better)0.97
Interest coverage10.9×–
Current ratio3.464.86 (better)
Altman Z-score4.6412.92 (better)
Piotroski F-score47 (better)
Dividends and buybacks
Dividend yield–2.4%
Payout ratio–84.5%
Years of dividend growth–16
Dividend growth, 5Y average–8.1%
Buyback yield5.3% (better)0.26%
Shareholder yield5.3% (better)2.7%
Ownership
Held by institutions104%89.5%
Held by insiders0.52%0.16%
Insider net buying, 12 months−$20.1M (better)−$119M
Superinvestors holding–8
Short interest, % of float7.7%2.2%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.